Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyurea for Acute Vaso-Occlusive Crisis in Sickle Cell Anemia
NCT03062501Phase 2Unknown
- Sponsor
- HEMORIO
- Start
- Nov 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxyurea in sickle cell anemia (SCA), sponsored by HEMORIO. Status: unknown.
02
Drugs
hydroxyurea
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT03062501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03062501.